Philadelphia, PA, May 17, 2001 – William P. Vaughan, MD, MBA, was recently elected Chairman of the Board of Directors for the National Comprehensive Cancer Network (NCCN).
Dr. Vaughan is the Associate Director for Clinical Affairs and Director of the Bone Marrow Transplantation Program at the University of Alabama at Birmingham (UAB) Comprehensive Cancer Center. UAB is a member institution of the NCCN.
Dr. Vaughan received his medical degree from the University of Connecticut School of Medicine. His postgraduate training included a residency at University of Chicago Hospitals and Clinics and a fellowship in oncology and internal medicine at The Johns Hopkins University School of Medicine. Dr. Vaughan received his Masters of Business Administration from University of Alabama.
"Dr. Vaughan's expertise and experience in both academic medicine and in business will facilitate the continued growth of the NCCN's influence in cancer care in this country and abroad," said Dr. William T. McGivney, Chief Executive Officer of NCCN, in announcing Dr. Vaughan's election as Chairman.
Dr. Vaughan will succeed Robert C. Young, MD as Chairman. Dr. Young, President of Fox Chase Cancer Center, another NCCN member institution, is President-elect of the American Cancer Society.
The NCCN, an alliance of 19 of the world's leading cancer centers, was established in 1995 to provide the state-of-the-art in cancer care to the greatest number of patients in need. The NCCN is dedicated to advancing the missions of its member institutions in education, research and patient care. As part of its mission, the NCCN serves as the most authoritative source of cancer information for health care professionals based upon the expertise and input of its world-renowned clinicians.
The NCCN member institutions are: The Arthur G. James Cancer Hospital & Richard J. Solove Research Institute at Ohio State University, Columbus; City of Hope Cancer Center, Los Angeles; Dana-Farber Cancer Institute, Boston; Duke Comprehensive Cancer Center, Durham; Fox Chase Cancer Center, Philadelphia; Fred Hutchinson Cancer Research Center, Seattle; H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida, Tampa; Huntsman Cancer Institute at the University of Utah, Salt Lake City; Johns Hopkins Comprehensive Cancer Center, Baltimore; Memorial Sloan-Kettering Cancer Center, New York; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago; Roswell Park Cancer Institute, Buffalo; St. Jude Children's Research Hospital, Memphis; Stanford Hospital & Clinics, Stanford; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham; University of California San Francisco Comprehensive Cancer Center, San Francisco; University of Michigan Comprehensive Cancer Center, Ann Arbor; UNMC/Eppley Cancer Center at the University of Nebraska Medical Center, Omaha.; and University of Texas M. D. Anderson Cancer Center, Houston.